The CRL was given because the FDA did not consider the phase 1/2 IGNYTE trial to be an adequate and well-controlled clinical ...

Medpace beats Q2 2025 earnings, raises FY guidance, showcasing strong biotech demand. Click here to read an analysis of MEDP ...

Monte Rosa Therapeutics has dosed the first participants in the Phase I trial of the NEK7-directed molecular glue degrader (MGD), MRT-8102.

Detailed price information for Amylyx Pharmaceuticals Inc (AMLX-Q) from The Globe and Mail including charting and trades.

View the latest Lalpir Power Ltd. (LPL) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Tata Textile Mills Ltd. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View TATM.PK financial statements in full.